Observational & Pragmatic Research Institute UK (OPRI UK)
This sponsor has funded 1 studies across 19 countries.
| EU PAS ID | Status | RMP requirement | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|---|
| 104709 | Planned | Not included in RMP | The UK nationwide cardiorespiratory impact of the COVID-19 pandemic | No | No |
PAS by Risk Management Plan (RMP) requirement
Observational & Pragmatic Research Institute UK (OPRI UK)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Observational & Pragmatic Research Institute UK (OPRI UK)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Observational & Pragmatic Research Institute UK (OPRI UK)
19 Study countries specified are the following:
- Argentina
- Australia
- Bulgaria
- Canada
- Colombia
- Denmark
- Greece
- India
- Ireland
- Korea, Republic of
- Kuwait
- Mexico
- Portugal
- Saudi Arabia
- Spain
- Taiwan
- United Arab Emirates
- United Kingdom
- United States